Explore
Validate
Learn
Western blot
ELISAAntibody data
- Antibody Data
- Antigen structure
- References [2]
- Comments [0]
- Validations
- Western blot [1]
- Immunoprecipitation [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 16633-1-AP - Provider product page
- Provider
- Proteintech Group
- Proper citation
- Proteintech Cat#16633-1-AP, RRID:AB_2256547
- Product name
- RTF2 antibody
- Antibody type
- Polyclonal
- Description
- KD/KO validated RTF2 antibody (Cat. #16633-1-AP) is a rabbit polyclonal antibody that shows reactivity with human, mouse, rat and has been validated for the following applications: IF, IP, WB,ELISA.
- Reactivity
- Human, Mouse, Rat
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references RTF2 controls replication repriming and ribonucleotide excision at the replisome.
Removal of RTF2 from Stalled Replisomes Promotes Maintenance of Genome Integrity.
Conti BA, Ruiz PD, Broton C, Blobel NJ, Kottemann MC, Sridhar S, Lach FP, Wiley T, Sasi NK, Carroll T, Smogorzewska A
bioRxiv : the preprint server for biology 2023 Mar 13;
bioRxiv : the preprint server for biology 2023 Mar 13;
Removal of RTF2 from Stalled Replisomes Promotes Maintenance of Genome Integrity.
Kottemann MC, Conti BA, Lach FP, Smogorzewska A
Molecular cell 2018 Jan 4;69(1):24-35.e5
Molecular cell 2018 Jan 4;69(1):24-35.e5
No comments: Submit comment
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- HeLa cells were subjected to SDS PAGE followed by western blot with 16633-1-AP(C20orf43 antibody) at dilution of 1:500
- Sample type
- cell line
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- The C20orf43 antibody from Proteintech is a rabbit polyclonal antibody to a recombinant protein of human C20orf43. This antibody recognizes human,mouse,rat antigen. The C20orf43 antibody has been validated for the following applications: ELISA, WB, IP analysis.
